← Back to Search

Antibiotic

Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)

Phase 2
Waitlist Available
Research Sponsored by Bradley Connor
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month after treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new antibiotic called AEMCOLO to see if it can help people with Small Intestinal Bacterial Overgrowth (SIBO). AEMCOLO aims to reduce the excessive bacteria in the small intestine, which can cause digestive problems. The study will determine the most effective dose.

Eligible Conditions
  • Gastroenteritis
  • Small Intestinal Bacterial Overgrowth
  • Gastrointestinal Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month after treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To assess the change of an abnormal breath test followed by a regimen of AEMCOLO
Secondary study objectives
To evaluate the change in clinical symptoms followed by a regimen of AEMCOLO

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2nd regimenExperimental Treatment1 Intervention
15 patients will receive AEMCOLO (Rifamycin SV MMX) 194 mg tablets to take two tablets three times daily for 14 days (84 Tablets).
Group II: 1st regimenExperimental Treatment1 Intervention
15 patients will receive AEMCOLO (Rifamycin SV MMX) 194 mg two tablets to take twice daily for 14 days (56 Tablets)

Find a Location

Who is running the clinical trial?

Bradley ConnorLead Sponsor
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top